164 related articles for article (PubMed ID: 16175569)
1. Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia.
Andersson M; Terasmaa A; Fuxe K; Strömberg I
J Neurosci Res; 2005 Oct; 82(2):264-72. PubMed ID: 16175569
[TBL] [Abstract][Full Text] [Related]
2. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
Sóvágó J; Makkai B; Gulyás B; Hall H
Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
[TBL] [Abstract][Full Text] [Related]
3. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P
Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
[TBL] [Abstract][Full Text] [Related]
4. Increased dopamine receptor signaling and dopamine receptor-G protein coupling in denervated striatum.
Cai G; Wang HY; Friedman E
J Pharmacol Exp Ther; 2002 Sep; 302(3):1105-12. PubMed ID: 12183669
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.
Marcellino D; Carriba P; Filip M; Borgkvist A; Frankowska M; Bellido I; Tanganelli S; Müller CE; Fisone G; Lluis C; Agnati LF; Franco R; Fuxe K
Neuropharmacology; 2008 Apr; 54(5):815-23. PubMed ID: 18262573
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims.
Hungund BL; Vinod KY; Kassir SA; Basavarajappa BS; Yalamanchili R; Cooper TB; Mann JJ; Arango V
Mol Psychiatry; 2004 Feb; 9(2):184-90. PubMed ID: 14966476
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
Odagaki Y; Toyoshima R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
[TBL] [Abstract][Full Text] [Related]
9. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.
Joyce JN
Synapse; 2001 May; 40(2):137-44. PubMed ID: 11252025
[TBL] [Abstract][Full Text] [Related]
10. Histamine H3 and dopamine D2 receptor-mediated [35S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions.
Humbert-Claude M; Morisset S; Gbahou F; Arrang JM
Biochem Pharmacol; 2007 Apr; 73(8):1172-81. PubMed ID: 17306767
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
[TBL] [Abstract][Full Text] [Related]
12. Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.
Rodríguez-Gaztelumendi A; Rojo ML; Pazos A; Díaz A
J Neurochem; 2009 Mar; 108(6):1423-33. PubMed ID: 19183263
[TBL] [Abstract][Full Text] [Related]
13. Risperidone treatment increases CB1 receptor binding in rat brain.
Secher A; Husum H; Holst B; Egerod KL; Mellerup E
Neuroendocrinology; 2010; 91(2):155-68. PubMed ID: 19815998
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction pathway activity compensates dopamine D₂/D₃ receptor density changes in Parkinson's disease: a preliminary comparative human brain receptor autoradiography study with [³H]raclopride and [³⁵S]GTPγS.
Farkas S; Nagy K; Jia Z; Hortobágyi T; Varrone A; Halldin C; Csiba L; Gulyás B
Brain Res; 2012 May; 1453():56-63. PubMed ID: 22480734
[TBL] [Abstract][Full Text] [Related]
15. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
Heinrich JN; Brennan J; Lai MH; Sullivan K; Hornby G; Popiolek M; Jiang LX; Pausch MH; Stack G; Marquis KL; Andree TH
Eur J Pharmacol; 2006 Dec; 552(1-3):36-45. PubMed ID: 17056032
[TBL] [Abstract][Full Text] [Related]
16. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
Alttoa A; Eller M; Herm L; Rinken A; Harro J
Brain Res; 2007 Feb; 1131(1):138-48. PubMed ID: 17156751
[TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
18. Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment.
Geurts M; Hermans E; Maloteaux JM
Eur J Pharmacol; 1999 Oct; 382(2):119-27. PubMed ID: 10528146
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term biogenic amine transporter blockade on receptor/G-protein coupling in rat brain.
O'Connor KA; Gregg TC; Davies HM; Childers SR
Neuropharmacology; 2005 Jan; 48(1):62-71. PubMed ID: 15617728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
